Study proves effectiveness of Artemisia annua against SARS-CoV-2 in vitro

A multinational research group has been the first to show the excellent activity of artemisinin-based treatment against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human cell lines – including a specific type of lung cells. Their findings were recently published in the journal Scientific Reports.

IJMS, Free Full-Text

Frontiers Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand

Plants, Free Full-Text

Study looks at potent phytocompounds from Himalayan herbs to treat COVID-19

Early Research Finds Extracts from Sweet Wormwood Plant Can Inhibit the COVID-19 Virus

Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective

Chemical and spectroscopic characterization of (Artemisinin/Querctin/ Zinc) novel mixed ligand complex with assessment of its potent high antiviral activity against SARS-CoV-2 and antioxidant capacity against toxicity induced by acrylamide in male rats [

Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach

Saponin and Immune Stimulant Based Gargles and Nasal Rinses: A Potential Virucidal for Preventive Management of SARS-CoV-2 Infection?

Green Artemisia Annua Plant at Rs 25/piece in Ghaziabad, artemisia annua

In vitro efficacy of Artemisia extracts against SARS-CoV-2, Virology Journal

In vitro efficacy of Artemisia extracts against SARS-CoV-2

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2 - ScienceDirect

Biomolecules, Free Full-Text